The cardiotoxicity of antimalarials
The cardiotoxicity of antimalarial medicines has received renewed interest in recent years following the ‘Thorough QT’ assessment of the dihydroartemisinin-piperaquine formulation approved by the European Medicines Agency, which showed evidence of QT interval prolongation. Piperaquine is a bisquinol...
| Autres auteurs: | |
|---|---|
| Format: | Report |
| Publié: |
World Health Organization
2017
|